Drug interactions in cancer patients: A hidden risk?

por Riechelmann, Rachel, Girardi, Daniel
Publicado 2016

Drug interactions and oncological outcomes: a hidden adversary

por Riechelmann, Rachel P, Krzyzanowska, Monika K
Publicado 2019

Anal canal cancer in Brazil: why should we pay more attention to the epidemiology of this rare disease?

por Donadio, Mauro DS, Riechelmann, Rachel P
Publicado 2020

Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s Perspective

por de Jesus, Victor Hugo Fonseca, Riechelmann, Rachel P.
Publicado 2023

Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges

por Rocha, Lucila Soares da Silva, Riechelmann, Rachel P.
Publicado 2018

Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayesian netw...

por de Jesus, Victor Hugo Fonseca, Riechelmann, Rachel P
Publicado 2021

Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian net...

por de Jesus, Victor Hugo Fonseca, Riechelmann, Rachel P
Publicado 2021

A systematic review of therapeutic strategies in gastroenteropancreatic grade 3 neuroendocrine tumors

por Donadio, Mauro D., Brito, Ângelo B., Riechelmann, Rachel P.
Publicado 2023

Adherence to colonoscopy recommendations for first-degree relatives of young patients diagnosed with colorectal cancer

por Garcia, Guilherme H, Riechelmann, Rachel P, Hoff, Paulo M
Publicado 2015

Complications from carcinoid syndrome: review of the current evidence

por Mota, José Mauricio, Sousa, Luana Guimarães, Riechelmann, Rachel P
Publicado 2016

Recurrence-free survival as a putative surrogate for overall survival in phase III trials of curative-intent treatment of colorectal liver metastases: Systematic review

por Araujo, Raphael L C, Herman, Paulo, Riechelmann, Rachel P
Publicado 2017

Efficacy and safety of FLOT regimen vs DCF, FOLFOX, and ECF regimens as perioperative chemotherapy treatments for resectable gastric cancer patients; a report from the middle east

por Farrokhi, Pegah, Sadeghi, Alireza, Sharifi, Mehran, Riechelmann, Rachel, Moghaddas, Azadeh
Publicado 2022

Carcinoid syndrome: update on the pathophysiology and treatment

por de Celis Ferrari, Anezka C. Rubin, Glasberg, João, Riechelmann, Rachel P
Publicado 2018

High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease

por Alves, Carolina, Mesquita, Marcella, Silva, Carolina, Soeiro, Maria, Hajjar, Ludhmila, Riechelmann, Rachel P
Publicado 2018

Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A S...

por Carvalho de Brito, Angelo Borsarelli, Riechelmann, Rachel P, Fonseca de Jesus, Victor Hugo
Publicado 2023

Li–Fraumeni-associated pancreatic neuroendocrine tumour and XAF1 p.Glu134Ter risk modifier variant

por Riechelmann, Rachel P, Soares, Diogo C, Dias, Carla, Carraro, Dirce M, Torrezan, Giovana T
Publicado 2022

Unresectable metastatic colorectal cancer in fit patients – a practical algorithm of treatment sequencing from the Brazilian Group of Gastrointestinal Tumours (GTG)

por Peixoto, Renata D’Alpino, Coutinho, Anelisa K, Prolla, Gabriel, Weschenfelder, Rui F, Riechelmann, Rachel
Publicado 2023

Functional pancreatic neuroendocrine tumour causing Cushing’s syndrome: the effect of chemotherapy on clinical symptoms

por do Amor Divino, Paulo Henrique, Marchetti, Katia Regina, Almeida, Madson Q, Riechelmann, Rachel P
Publicado 2017

Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status

por Fiorin de Vasconcellos, Vitor, RCC Bonadio, Renata, Avanço, Guilherme, Vailati Negrão, Marcelo, Pimenta Riechelmann, Rachel
Publicado 2019

Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer

por de Jesus, Victor H. F., Camandaroba, Marcos P. G., Calsavara, Vinicius F., Riechelmann, Rachel P.
Publicado 2020